Abdominal fat and health risks

What abdominal fat is and why it matters

Abdominal fat is one of the strongest single predictors of cardiometabolic disease in men. Four points cover the basics every man should understand.

1. Subcutaneous versus visceral fat: not the same tissue

Two distinct types of fat sit around the midsection. Subcutaneous fat sits just under the skin. This is the soft fat you can pinch. It is largely a passive storage tissue with limited metabolic activity. Visceral fat sits deeper inside the abdominal cavity wrapped around organs including the liver, pancreas, intestines and kidneys. This is the firmer fat that pushes the belly out from the inside. Visceral fat is metabolically active and behaves like an endocrine organ. A man can have modest total body fat but elevated visceral fat with substantial health risk. The two types respond similarly to diet and exercise but visceral fat tends to reduce first.

2. Why visceral fat drives disease: the inflammatory factory

Visceral adipose tissue actively secretes inflammatory cytokines including TNF-alpha and interleukin-6. It releases free fatty acids directly into the portal vein feeding the liver. It contains aromatase enzyme that converts testosterone to oestradiol. Combined these effects drive insulin resistance, chronic low-grade systemic inflammation, hepatic fat accumulation, altered lipid profiles and cardiovascular damage. The INTERHEART study published in The Lancet in 2004 documented that waist to hip ratio predicted heart attack risk more reliably than body mass index. The mechanism: visceral fat is not just stored energy but an active driver of disease.

3. Why men store fat differently from women

Men typically deposit fat around the midsection (the apple shape) while women typically deposit fat around hips and thighs (the pear shape). The pattern reflects sex hormone influence. Testosterone promotes abdominal fat storage in men particularly after age 35. Oestrogen in pre-menopausal women directs fat toward subcutaneous gluteofemoral depots which are less metabolically harmful. This is one reason men face cardiometabolic risk earlier in life on average than women. After menopause women lose oestrogen protection and develop a more male-pattern fat distribution with increasing midlife metabolic risk.

4. Waist circumference matters more than the scale

Body mass index (BMI) misses important information about where fat sits. A 95kg man with strong muscle mass and modest visceral fat can have the same BMI as a 95kg man with low muscle and high visceral fat. The first has minimal cardiometabolic risk. The second has substantial risk. Waist circumference captures the abdominal fat distribution that BMI misses. NHS guidance recommends waist measurement alongside BMI for risk assessment. For men of South Asian, Chinese or Japanese ethnicity the waist thresholds are lower (above 90cm rather than 94cm) because metabolic risk appears at lower body sizes.

What abdominal fat actually does to men

Five major disease categories link directly to elevated visceral fat in men.

Cardiovascular disease

Abdominal fat is one of the strongest modifiable predictors of heart attack and stroke in men. The 2004 INTERHEART study covering over 27,000 participants across 52 countries documented that waist to hip ratio predicted myocardial infarction risk more reliably than BMI. The 2007 EPIC-Norfolk cohort produced similar findings in UK populations. Mechanisms include insulin resistance, dyslipidaemia (raised triglycerides, lowered HDL), elevated blood pressure and chronic inflammation that accelerates atherosclerosis. Men with waist above 102cm have roughly double the cardiovascular event rate of men with waist below 94cm at equivalent age.

Type 2 diabetes

Visceral fat is the strongest reliable predictor of type 2 diabetes development in men. The free fatty acids released into the portal vein drive hepatic insulin resistance. Inflammatory cytokines impair muscle glucose uptake. The combination raises fasting glucose and HbA1c progressively. The DiRECT trial published in The Lancet in 2018 demonstrated that intensive caloric restriction producing substantial visceral fat loss could induce type 2 diabetes remission in many patients within months. Visceral fat is not just a marker of diabetes risk but a causal mechanism that responds to intervention.

Cancer (particularly colorectal)

Elevated abdominal fat increases risk for several cancers in men. The strongest evidence is for colorectal cancer where Cancer Research UK estimates around 11 percent of cases relate to overweight or obesity. Prostate cancer (particularly aggressive forms), pancreatic cancer, kidney cancer, oesophageal adenocarcinoma and liver cancer also show elevated risk with abdominal obesity. Mechanisms include chronic inflammation, altered insulin and IGF-1 signalling, sex hormone alterations and visceral fat-driven oxidative stress. Cancer is a major reason abdominal fat matters even for men focused on cardiovascular outcomes.

Non-alcoholic fatty liver disease (NAFLD)

The free fatty acids visceral fat dumps into the portal vein feed the liver directly. Over time fat accumulates within liver cells producing non-alcoholic fatty liver disease, now the most common chronic liver condition in the UK. Estimates suggest around 25 percent of UK adults have some degree of NAFLD often without symptoms. A subset progresses to non-alcoholic steatohepatitis (NASH) with inflammation and scarring, then fibrosis and cirrhosis. Men with central obesity have substantially higher NAFLD prevalence. Liver function tests (ALT, AST, GGT) and ultrasound can identify the condition.

Sleep apnoea, low testosterone and mental health

Three further consequences cluster around abdominal obesity in men. Obstructive sleep apnoea occurs when neck and upper-airway fat narrows the airway during sleep. Around 80 percent of men with significant sleep apnoea are overweight with central obesity. Symptoms include heavy snoring, daytime fatigue, morning headaches. Low testosterone develops through the aromatase pathway and through sleep apnoea disrupting nocturnal testosterone production. Symptoms include low libido, fatigue, mood changes, loss of muscle mass. Mental health connections include elevated rates of depression and anxiety associated with metabolic dysfunction though causation runs both directions.

When to see your GP about abdominal fat

Specific signs warrant professional input rather than self-directed lifestyle change alone.

• Waist circumference above 102cm (40 inches). NHS threshold for substantially increased risk. Worth a baseline check including blood pressure, fasting glucose, HbA1c, lipid panel, liver function tests and testosterone.
• Family history of early heart disease or type 2 diabetes. Genetic predisposition combined with central adiposity escalates risk. Earlier and more comprehensive screening appropriate.
• Symptoms of metabolic syndrome. Persistent fatigue, frequent urination, persistent thirst, blurred vision, raised blood pressure readings at home. These suggest insulin resistance progressing toward diabetes.
• Heavy snoring or daytime sleepiness. Possible obstructive sleep apnoea. Treatable with CPAP and weight reduction. Often missed because partners report it but men do not perceive symptoms during sleep.
• Sudden unexplained increase in waist. Particularly fluid accumulation rather than fat. Can indicate liver, heart or kidney problems requiring investigation.

For men who fit standard risk patterns without symptoms a sensible approach combines waist measurement quarterly, a baseline GP check at age 40 if not done already, and lifestyle change focused on caloric balance, strength training, reduced ultra-processed food and reduced alcohol. Visceral fat responds quickly to consistent intervention. A 5 to 10 percent body weight loss often produces disproportionate visceral fat reduction and meaningful cardiometabolic improvement.

Related risks for men

Several pages cover related cardiometabolic topics. Our piece on Type 2 Diabetes Risk in Men covers the diabetes side of central adiposity. Heart Disease Risk in Men covers the cardiovascular consequences in detail. And Male Metabolic Health Explained covers the broader picture of metabolic dysfunction in men.